Apollo’s Covis sues over preterm-birth drug patents

05-01-2021

Muireann Bolger

Apollo’s Covis sues over preterm-birth drug patents

sruilk / Shutterstock.com

Aurobindo’s subsidiary Eugia allegedly infringed two patents for an injectable treatment for reducing the risk of premature birth, according to a lawsuit by Covis Pharma, a Luxembourg-based unit of Apollo Global Management.


Apollo, Eugia, Covis, Aurobindo, Makena, Hydroxyprogesterone caproate, generics

LSIPR